Prognostic value of plasma biomarkers for informing clinical trial design in mild-to-moderate Alzheimer's disease. uri icon

authors

  • Qiu, Yuqi
  • Askew, Brianna
  • Donahue, Lia
  • Kaplita, Stephen
  • Coric, Vladimir
  • Qureshi, Irfan A
  • Feldman, Howard H
  • Jacobs, Diane M
  • Messer, Karen
  • Salmon, David P
  • Wellington, Cheryl L
  • Stukas, Sophie
  • Revta, Carolyn
  • Brewer, James B
  • Léger, Gabriel C

publication date

  • May 2, 2025